Anticonvulsants for cocaine dependence

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Minozzi, Silvia ^a   Amato, L ^a   Davoli, M ^a   Farrell, M ^a   Lima Reisser, A A R L ^a   Pani, P P ^a   Silva De Lima, M ^a   Soares, B ^a   Vecchi, S ^a  

^a ASL RM E ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DESIPRAMINE; GABAPENTIN; LAMOTRIGINE; METHADONE; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ALCOHOLISM; ANXIETY DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONFIDENCE INTERVAL; DATA ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; GENERALIZED ANXIETY DISORDER; HAMILTON SCALE; HUMAN; INFORMATION PROCESSING; MAJOR DEPRESSION; MENTAL DISEASE; PATIENT COUNSELING; POSITIVE AND NEGATIVE SYNDROME SCALE; PREGNANT WOMAN; PROFILE OF MOOD STATES; PSYCHOPATHY; PSYCHOSOCIAL CARE; QUALITY CONTROL; RATING SCALE; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 44949220176     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006754.pub2     Document Type: Review

References (97)

1. Berger 2005 arm a {published data only} *Berger PS, Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Leiderman DB, et al.A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction 2005;100(Suppl 1):58-67.
2. Berger 2005 arm b {published data only} *Berger PS, Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Leiderman DB, et al.A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction 2005;100(Suppl 1):58-67.
3. Bisaga 2006 {published data only} *Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, et al.A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug and alcohol Dependence 2006;81(3):267-74.
4. Campbell 1994 arm a {published data only} *Campbell JL, Thomas HM, Gabrielli W, Liskow BI, Powell BJ. Impact of Desipramine or Carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings. Journal of Addictive Diseases 1994;13(4):191-9.
5. Campbell 1994 arm b {published data only} *Campbell JL, Thomas HM, Gabrielli W, Liskow BI, Powell BJ. Impact of Desipramine or Carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings. Journal of Addictive Diseases 1994;13(49:191-9.
6. Campbell 2003 arm a {published data only} *Campbell J, Nickel EJ, Penick EC, Wallace D, Gabrrelli WF, Rowe C, et al.Comparison of desipramine or carbamazepine to placebo for crack cocaine dependent patients. Am J Addict 2003;12:122-36.
7. Campbell J, Nickel EJ, Penlick EC, Liskow B, Powell BJ. Gender differences in pharmacologic treatment for cocaine dependence. NIDA Research monograph. 1999; Vol. 54.
8. Campbell L, Thomas HM, Gabrielli WF, Samuelson SD. Efficacy and compliance with carbamazepine and desipramine versus placebo for cocaine abusers. NIDA Research Monograph. 1996; Vol. 162: 147.
9. Campbell 2003 arm b {published data only} *Campbell J, Nickel EJ, Penick EC, Wallace D, Gabrrelli WF, Rowe C, et al.Comparison of desipramine or carbamazepine to placebo for crack cocaine dependent patients. Am J Addict 2003;12:122-36.
10. Cornish 1995 {published data only} *Cornish JW, Manny I, Fudala PJ, Neal S, Poole SA, Volpicelli P, et al.Carbamazepine treatment for cocaine dependence. Drug and Alcohol Dependence 1995;38(3):221-7.
11. Crosby 1996 {published data only} *Crosby RD, Pearson VL, Eller C, Winegarden T, Graves NL. Phentoin in the treatment of cocaine abuse: a double blind study. Clinical Pharmacology & Therapeutics 1996;59(4):458-68.
12. Gonzalez 2003 arm a {published data only} *Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, et al.Tiagabine increases cocaine-free urines in cocaine-dependent methadone-trated patients: results of a randomized pilot study. Addiction 2003;98(11):1625- 32.
13. Gonzalez 2003 arm b {published data only} *Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, et al.Tiagabine increases cocaine-free urines in cocaine-dependent methadone-trated patients: results of a randomized pilot study. Addiction 2003;98(11):1625- 32.
14. Gonzalez 2007 arm a {published data only} *Gonzalez G, Desai R, Sofuoglu M, Poling J, Oliveto A, Gonsai K, et al.Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug and Alcohol Dependence 2007;87(1):1-9.
15. Gonzalez 2007 arm b {published data only} *Gonzalez G, Desai R, Sofuoglu M, Poling J, Oliveto A, Gonsai K, et al.Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug and Alcohol Dependence 2007;87(1):1-9.
16. Halikas 1997 arm a {published data only} Halikas JA, Crosby RD, Koop LP, Crea F, Nugent SM, Carlson GA. Daily monitored cardiovascular effects of Carbamazepine in chronic crack cocaine use. Psychopharmacological Bullettin 1991;27(3):345-51.
17. *Halikas JA, Crosby RD, Pearson VL, Graves NM. A randomized double-blind stuidy of carbamazepine in the treatment of cocaine abuse. Clinical Pharmacology and Therapeutics 1997;62(1):89-105.
18. Halikas 1997 arm b {published data only} Halikas JA, Crosby RD, Koop LP, Crea F, Nugent SM, Carlson GA. Daily monitored cardiovascular effects of Carbamazepine in chronic crack cocaine use. Psychopharmacological Bullettin 1991;27(3):345-51.
19. *Halikas JA, Crosby RD, Pearson VL, Graves NM. A randomized double-blind stuidy of carbamazepine in the treatment of cocaine abuse. Clinical Pharmacology and Therapeutics 1997;62(1):89-105.
20. Kampman 2004 {published data only} *Kampan KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, et al.A pilot trial of topiramate for the treatment of cocaine dependence. Drug and Alcohol Dependence 2004;75(3):233-40.
21. Kranzler 1995 {published data only} Hersh D, Bauer LO, Kranzler HR. Carbamazepine and cocaine-cue reactivity. Drug and Alcohol Dependence 1995;39:213-21.
22. *Kranzler HR, Bauer LO, Hersh D, Klinghoffer V. Carbamazepine treatment of cocaine dependence: a placebo-controlled trial. Drug and Alcohol Dependence 1995;38(3):203-11.
23. Montoya 1994 {published data only} *Montoya ID, Levin FR, Fudala PJ, Gorelick DA. Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence. Drug and Alcohol Dependence 1995;38(3):213-9.
24. Reid 2005 {published data only} *Reid MS, Casadonte P, Baker S, Sanfilippo M, Braunstein D, Hitzemann R, et al.A placbo-controlled screening trial of olanzapine, valproate and coenzyme Q10/L-carnitine for the treatment of cocaine dependence. Addiction 2005;100(Suppl 1):43-57.
25. Sofuoglu 1999 {published data only} *Sofuoglu M, Pentel PR, Bliss RL, Goldman AI, Hatsukami DK. Effects of phenytoin on cocaine self-administration in humans. Drug and Alcohol Dependence 1999;53(3):273-5.
26. Winhusen 2005 {published data only} *Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Montgomery MA, Goldsmith RJ, et al.A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 2005;100(Suppl 1):68-77.
27. Ahmadi 2006 Ahmadi J, Kampman K, Dackis C. Outcome predictors in cocaine dependence treatment trials. The American journal of Addiction Psychiatry 2006;15(6):434-9.
28. Brady 2002 Brady KT, Sonne SC, Malcolm RJ, Randall CL. Carbamazepine in the teratment of cocaine dependence: subtyping by affective disorders. Experimental and clinical pharmacology 2002;10(3):276- 85.
29. Brown 2003 Brown ES, Nejtek VA, Perantie DC, Orsulak PJ, Bobadilla LB. Lamotrigine in patients with bipolar disorder and cocaine dependence. Journal of Clinical Psychiatry 2003;64(2):198-201.
30. Campbell 2001 Campbell J, Gorodetzky C, Nickel J, Pennick E. Does worse precidt better? Characteristics and putcomes of vlunteers for a medication trila or Psychosocial trial. Drud and Alcohol Dependence. Sixty-Thrid Annual ScientificMeetind Scottsdale, Arizona. 2001; Vol. Vol. 63 supplement 1, S23.
31. Cornish 1995 b Cornish JW, Maany I, Fudala PJ, Poole SA, O'Brien CP. An analysis of factors influencing subject participation in a trial of carbamazepine for cocaine dependence treatment. NIDA Research Monograph. 1995; Vol. 135, issue 312.
32. Elkashef 2005 Elkashef A, Holmes TH, Bloch DA, Shoptaw S, Kampman K, Reid MS. Retrospective analyses of pooled data from CREST I and CREST II trials for tratment of cocaine dependence. Addiction 2005; 100(Suppl 1):91-101.
33. Gorelick 1994 Gorelick DA, Weinhold LL, Cone EJ, Henningfield JE. Carbamazepine (CBS) does not alter cocaine self-administration in human cocaine addicts. NIDA Research Monograph. 1994; Vol. 141:137.
34. Halikas 1989 Halikas J, Kemp K, Kuhn K, Carlson G, Crea F. Carbamazepine for cocaine addiction. The Lancet 1989;1(8638):623- 4.
35. Halikas 1991 Halikas JA, Crosby RD, Carlson GA, Crea F, Graves NM, et al.Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short term, double blind cross over design. Clin Pharmacol Ther 1991;50:81-95.
36. Haney 2005 Haney M, Hart C, Collins ED, Foltin RW. Smoked cocaine discrimination in humans: effects of gabapentin. Drug and Alcohol dependence 2005;80(1):53-61.
37. Hart 2004 Hart CL, Waerd AS, Collins ED, Haney M, Foltin RW. Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug and Alcohol Dependence 2004;73(3):279-87.
38. Hart 2007 Hart CL, Haney M, Collins ED, Rubin E, Foltin RW. Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug and Alcohol Dependence 2007;86(2-3):274-7.
39. Hatsukami 1991 Hatsukami D, Keenan R, Halikas J, Pentel PR, Brauer LH. Effects of carbazepine on acute responses to smoked cocaine-base in human cocaine users. Psychopharmacology 1991;104:120-4.
40. Johnoson 2005 Johnson BA. Recent advances in the development of treatments for alcohol and cocaine dependence. CNS Drugs 2005;19(10):873-96.
41. Kampman 2005 Kampman KM, Leiderman D, Holmes T, LoCastro J, Bloch DA, Reid MS, et al.Cocaine rapid efficacy screening trials (CREST): lessons learned. Addiction 2005;100(Suppl 1):102-10.
42. Khun 1989 Kuhn KL, Halikas JA, Kemp KD. Carbamazepine treatment of cocaine dependence in methadone maintenance patient with dual opiate-cocaine addiction. NIDA Research Monograph. 1989; Vol. 95, issue 316-17.
43. Leiderman 2005 Leiderman DB, Shoptaw S, Montgomery A, Bloch DA, Elkashef A, LoCastro JL, et al.Cocaine rapid efficacy screening trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence. Addiction 2005;100(Suppl 1):1-11.
44. Salloum 2007 Salloum IM, Douaihy A, Cornelius JR, Kirisci L, Kelly TM, Hayes J. Divalproex utility in bipolar disorder with co-occuring cocaine dependence: a pilot study. Addictive Behaviors 2007;32(2):410-5.
45. Sofuoglu 2005 Sofuoglu M, Poling J, Mitchell E, Kosten TR. Tiagabine affects the subjective response to cocaine in humans. Pharmacology, Biochemistry and Behavior 2005;82(3):569-73.
46. Vocci 2005 Vocci FJ, Elkashef A. Pharmacotherapy and other treatments for cocaine abuse and dependence. Current Opinion in Psychiatry 2005;18:235-70.
47. Winter 2000 Winther LC, Saleem R, McCance-Katz EF, Rosen MI, Hameedi FA, Pearsall HR, et al.Effects of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects. American journal Drug and Alcohol Abuse 2000;26(1):47-59.
48. Zullino 2004 Zullino DF, Khazaal Y, Hattenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs of Today 2004;40(7):603-19.
49. Fitterling 1995
50. Llosa 1994
51. Gonzalez 2006 Effectiveness of tiagabine for cocaine dependence in methadone maintenance individuals. Ongoing study December 2004.
52. Jenkins-Mendoza 2005 Effectiveness of topiramate in treating cocaine dependent individuals. Ongoing study October 2005.
53. Amato 2007 Amato L, Minozzi S, Pani PP, Davoli M. Antipsychotic medication for cocaine dependence. Cochrane Database of Systematic Reviews 2007, Issue 3.
54. Beck 1961 Beck AT, Word CH, Mendelson M, Mock J, Rebaugh J. An inventory for measuring depression. Archives of General Psichiatry 1961;4:461-71.
55. Campbell 1999 Campbell UC, Lac ST, Carroll ME. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 1999;143(2):209-14.
56. Chalmers 1993 Chalmers I. The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Annals of the New York Academy of Sciences 1993;703:156-63; discussion 163-5.
57. Craddok 1997 Craddok SG, Rounds-Bryant JL, Flinn PM, Hubbard RL. Characteristics and pre-treatment behaviours of clients entering drug abuse treatment: 1969 to 1993. American Journal of Drug and Alcohol Abuse 1997;23(1):43-59.
58. Crosby 1991 Crosby RD, Halikas JA, Carlson G. Pharmacotherapeutic interventions for cocaine abuse: present practices and future directions. Journal of Addictive Diseases 1991;10(4):13-30.
59. Czapinski 2005 Czapinski P, Blaszczyk B, Czuczwar SJ. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 2005;5(1):3- 14.
60. Davoli in press Davoli M, Pasqualini F, Belleudi V, Bargagli AM, Perucci CA. Changing pattern of drug abuse among patients entering treatment in Lazio, Italy, 1996-2003: transition from heroin to cocaine use. European Addiction Research.
61. Di Chiara 1988 Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 1988;85(14):5274-8.
62. Drevets 1999 Drevets WC, Price JC, Kupfer DJ, Kinahan PE, Lopresti B, Holt D, et al.PET Measures of Amphetamine-Induced Dopamine Release in Ventral versus Dorsal Striatum. Neuropsychopharmacology 1999;21(6):694-709.
63. Drevets 2001 Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, et al.Amphetamine-Induced Dopamine Release in Human Ventral Striatum Correlates with Euphoria. Biol Psychiatry 2001;49(2):81- 96.
64. DSM-IV-R American Psychiatric Association (Pb). Diagnostic and Statistical Manual of Mental Disorders. 4 edition. Washington DC: American Psychiatric Association, 1994.
65. EMCDDA 2006 The state of the drugs problem in the European Union and Norway. European Monitoring Centre for Drug and Drug Abuse, Luxemburg 2006.
66. Faggiano 2003 Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 3.
67. Grabowski 1997 Grabowski J, Roache JD, Scmitz JM, Rhoades H, Creson D, Korszun A. Replacement medication for cocaine dependence. Journal of Clinical Psychopharmacology 1997;17(6):485-8.
68. Guy 1976 Guy W. Assessment Manual for Psychopharmacology. Publication ADM 76-338. Washington DC: US Department of Health Education and Welfare, 1976.
69. Hamilton 1959 Hamilton M. The assessment of anxiety states by rating. British Journal Med Psycol 1959;32(1):50-5.
70. Hamilton 1967 Hamilton M. Development of a rating scale for primary depressive illness. British Journal Soc Clin Psychol 1967;6(4):278-96.
71. Higgins 1994 Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badjer GJ. Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence. Archives of General Psychiatry 1994;51(7):568- 76.
72. Higgins 2007 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library 2007, issue 2.
73. Karch 2006 Karch SB. A Brief History of Cocaine. 2nd Edition. New York, NY: CRC Press, 2006.
74. Knapp 2007 Knapp WP, Soares BGO, Farrel M, Lima MS. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database of Systematic Reviews 2007, Issue 3.Art. No.: CD003023. DOI:10.1002/14651858.CD003023.pub2.
75. Koob 1997 Koob GF, Nestler EJ. The neurobiology of drug addiction. Journal of Neuropsychiatry and Clinical Neurosciences 1997;9(3):482-97.
76. Kosten 1996 Kosten T, McCance E. A review of pharmacotherapies for substance abuse. American Journal of Addiction 1996;5(1):58-65.
77. Kushner 1999 Kushner SA, Dewey SL, Kornetsky C. The irreversible gamma-aminobutyric acid (GABA) trnsaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats. Journal of Pharmacology and Experimental Therapeutics 1999;290(2):792-802.
78. Landmark 2007 Landmark CJ. Targets for antiepileptic drugs in the synapse. Med Sci Monit. 2007 Jan;13(1) 2007;13(1):RA1-7.
79. Lima 2003 Lima MS, Reisser AAP, Soares BGO, Farrell M. Antidepressants for cocaine dependence. Cochrane Database of Systematic Reviews 2003, Issue 2.Art.No.: CD002950. DOI:10.1002/14651858.CD002950.
80. Lima Reisser 2000 Lima Reisser A, Lima MS, Soares BGO, Farrell M. Carbamazepine for cocaine dependence. Cochrane Database of Systematic Reviews 2000, Issue 2.Art. No.: CD002023. DOI: 10.1002/14651858.CD002023.
81. Mattick 2003 Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 2.Art. No.: CD002207. DOI:10.1002/14651858.CD002207.pub3.
82. McLellan 1992 McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al.The fifth edition of the Addiction Severity Index. Journal Substance Abuse Treatment 1992;9(3):199-213.
83. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported inmeta-analyses?. Lancet 1998;352(9128):609-13.
84. Moher 1999 Moher D, Cook DJ, Eastwood S, Olkin I, Drummond R, Stroup DF for the Quorum Group. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUORUM statement. Lancet 1999;354(9193):1896-900.
85. NSDUH 2005 Substance Abuse and Mental Health Services Administration (2005). Overview of Findings from the 2004 National Survey on Drug Use and Health (Office of Applied Studies, NSDUH Series H-27, DHHS Publication No. SMA 05-4061). Rockville, MD.
86. Ntais 2005 Ntais C, Pakos E, Panayiotis K, Ioannidis JPA. Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews 2005, Issue 3.Art. No.: CD005063. DOI: 10.1002/14651858.CD005063. pub2.
87. O'Brian 2001 O'Brian C. Drug addiction and drug abuse. In: HardmanJG, LeeCL editor(s). The pharmacological basis of Therapeutics. New York: MCGraw-Hill, 2001:621-42.
88. Policarpou 2005 Polycarpou A, Papanikolaou P, Contopoulos- Ioannidis DG, Ioannidis JPA. Anticonvulsants for the management of alcohol withdrawal. Cochrane Database of Systematic Reviews 2005, Issue 3.
89. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12.
90. Siliquini 2005 Siliquini R, Morra A, Versino E, Renga G. Recreational drug consumers: who seek treatment? European. Journal of Public Health 2005;15(6):580-6.
91. Soares 2003 Soares BGO, Lima MS, Reisser AAP, Farrell M. Dopamine agonists for cocaine dependence. Cochrane Database of Systematic Reviews 2003, Issue 2.Art. No.: CD003352. DOI: 10.1002/14651858.CD003352.
92. Somoza 1995 Somoza E, Dyrenforth S, Goldsmith J, Mezinskis J, Cohen M. In search of a universal drug craving scale. Annual Meeting of the American Psychiatric Association. 1995.
93. Sorensen 1991 Sorensen JL, Wermuth LA, Gibson DR, Choi K, Guydish JR. Preventing AIDS in drug abusers and their sexual partners. New York: Guilford, 1991.
94. Spielberg 1983 Spielberg DC. State-Trate Anxiety Inventory. Palo Alto CA: Consulting Psychologist Press, 1983.
95. Suelves 2001 Suelves JM, Brugal MT, Cayla JA, Torralba L. Change in health-related problems of cocaine consumption in Catalonia, Spain. Med Clin (Barc) 2001;117(15):581-3.
96. Topp 2003 Topp L, Day C, Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug & Alcohol Dependence 2003;70(3):275-86.
97. Volkow 2003 Volkow ND, Fowler JS, Wang GJ. The addicted human brain: Insights for imaging studies. Journal of Clinical Investigation 2003;111(10):1444-51.